Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease

Neurology

Volumn 64, Issue 3, 2005, Pages 459-462

  Hoff, Jana Midelfart ^a   Gilhus, Nils Erik ^a,b   Daltveit, Anne Kjersti ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Medical Birth Registry of Norway   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CESAREAN SECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DELIVERY; DEMOGRAPHY; DISABILITY; FEMALE; FORCEPS DELIVERY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INSTRUMENTAL DELIVERY; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

EID: 13244262603     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000150933.65709.96     Document Type: Article

References (32)

1. Rudnik-Schöneborn S, Röhrig D, Nicholson G, Zerres K. Pregnancy and delivery in Charcot-Marie-Tooth disease type 1. Neurology 1993;43: 2011-2016.
2. Reah G, Lyons GR, Wilson RC. Anaesthesia for caesarean section in a patient with Charcot-Marie-Tooth disease. Anaesthesia 1998;53:586.
3. Pollock M, Nukada H, Kritchevsky M. Exacerbation of Charcot-Marie-Tooth disease in pregnancy. Neurology 1983;32:1311-1134.
4. Lebo R. Prenatal diagnosis of Charcot-Marie-Tooth disease. Prenat Diagn 1998;18:169-172.
5. Bernard R, Boyer A, Negré P, et al. Prenatal detection of the 17p11.2 duplication in Charcot-Marie-Tooth disease type 1A: necessity of a multidisciplinary approach for heterogeneous disorders. Eur J Hum Genet 2002;10:297-302.
6. Medical Birth Registry of Norway. Annual report: 1999-2000. Bergen: National Institute of Public Health, University of Bergen.
7. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: I. Neurologic, genetic and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968;18:603-618.
8. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: II. Neurologic, genetic and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968;18:619-625.
9. Gjerde IO, Aarskog N, Vedeler C. Hereditary neuropathies with pressure palsies. Tidsskr Nor Lægeforen 2001;121:426-428.
10. Aarskog NK, Aadland S, Gjerde IO, Vedeler CA. Molecular genetic analysis of Charcot-Marie-Tooth 1A duplication in Norwegian patients by quantitative photostimulated luminescence imaging. J Neurol Sci 2001;188:21-26.
11. Aarskog NK, Vedeler CA. Recombination breakpoints in the Charcot-Marie-Tooth 1A repeat sequence in Norwegian families. Acta Neurol Scand 2001;104:97-100.
12. Kuhlenbäumer G, Young P, Hünennund G, Ringelstein B, Stögbauer F. Clinical features and molecular genetics of hereditary peripheral neuropathies. J Neurol 2002;249:1629-1650.
13. Backe B, Heggestad T, Lie T. Har keisersnittepidemien nådd Norge? Tidsskr Nor Lægeforen 2003;123:1522-1524.
14. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson M. Births: final data for 2002. Natl Vital Stat Rep 2003;52:1-114.
15. Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis - consequences for pregnancy, delivery and the newborn. Neurology 2003;61:1362-1366.
16. Chamberlain G, Steer P. ABC for labour care: operative delivery. Br Med J 1999;318:1260-1264.
17. Atlas I, Smolin A. Combined maternal and congenital myotonic dystrophy managed by a multidisciplinary team. Eur J Obstet Gynecol 1999; 87:175-178.
18. Bartlett DJ, Okun NB, Byrne PJ, Watt JM, Piper MC. Early motor development of breech- and cephalic-presenting infants. Obstet Gynecol 2000;95:425-432.
19. Jonas O, Roder D. Breech presentation in South Australia, 1987-1989. Aust. NZ J Obstet Gynecol 1993;33:17-21.
20. Rayl J, Gibson J, Hickok DE. A population-based case-control study of risk factors for breech presentation. Am J Obstet Gynecol 1996;174:28-32.
21. Bartlett D, Okun N. Breech presentation: a random event or an explainable phenomenon? Dev Med Child Neurol 1994;36:833-838.
22. Wilmshurst JM, Pollard JD, Nicholson G, Antony J, Ouvrier R. Peripheral neuropathies of infancy. Dev Med Child Neurol 2003;45:408-414.
23. Diagnosis and management of postpartum hemorrhage. ACOG technical bulletin no. 143 - July 1990. Int J Gynecol Obstet 1991;36:159-163.
24. Hardie R, Harding AE, Hirsch NP, Gelder C, Macrae AD, Thomas PK. Diaphragmatic weakness in hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 1990;53:348-350.
25. Gilchrist D, Chan CK, Deck JHN. Phrenic involvement in Charcot-Marie-Tooth disease. A pathological documentation. Chest 1989;96: 1197-1199.
26. Sulica L, Lovelace RE, Blitzer A, Kaufmann P. Vocal fold paresis of Charcot-Marie-Tooth disease. Ann Otol Rhinol Laryngol 2001;110: 1072-1076.
27. Stojkovic T, Seze J, Dubourg O, et al. Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin Neurophysiol 2003;114:1609-1614.
28. Thomas PK, Marques W, Davis MB, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997;120:465-478.
29. Sporrong B, Alm P, Owman C, Sjöberg N-O, Thorbert G. Pregnancy is associated with extensive adrenergic nerve degeneration in the uterus. An electron microscope study in the guinea-pig. Neuroscience 1981;6: 1119-1126.
30. Sereda MW, Hörste GM, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003;9:1533-1537.
31. Lawson VH, Gordon Smith A, Bromberg MB. Assessment of axonal loss in Charcot-Marie-Tooth neuropathies. Exp Neurol 2003;184:753-757.
32. Shy ME, Garbern JY, Kamholz J. Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol 2002;1:110-118.